Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Applied Molecular

Applied Molecular Evolution, Inc. (AME) is a leader in the application of directed molecular evolution to improve healthcare by optimizing and developing human biotherapeutics. AME uses its proprietary AMEsystem™ directed molecular evolution technology platform to optimize genes and therapeutic proteins for specific commercial purposes. AME optimizes the full range of proteins, including antibodies, cytokines, hormones and enzymes to develop improved versions of currently marketed, FDA-approved biotherapeutics as well as novel human biopharmaceuticals.

AME has collaborations with leading developers of biotherapeutics including Centocor, Lilly, Chiron, MedImmune, Bristol-Myers Squibb, Seattle Genetics, Cell Matrix and Biosynexus, whose biopharmaceutical projects may benefit from significant optimization of therapeutic and commercial parameters including:



Improved safety, efficacy and potency

Enhanced convenience

Decreased manufacturing costs

Broadened and lengthened patents


Contact Details:
3520 Dunhill Street
San Diego
CA
92121
United States of America
Tel:(858) 597-4990
Fax:(858) 597-4950
Email:
WWW:

www.amevolution.com/




Loading...

Recent Publications by Applied Molecular:

Arginine vasopressin receptor gene-based single-nucleotide polymorphism analysis in attention deficit hyperactivity disorder.
Sigma(E), encoded by rpoE, causes lysis of viable but nonculturable (VBNC)...
7th November, 2009
Department of Molecular Genetics, Applied Molecular Genomics Group Psychiatr Genet. 2009 Apr;19(2):102-3.
DOI Direct Link
Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer.
PURPOSE: Epidermal growth factor receptor (EGFR) tyrosine kinase...
4th November, 2009
Divisions of Medical Oncology/Hematology, Thoracic Surgery, and Chest J Clin Oncol. 2009 Nov 2.
DOI Direct Link
Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
This retrospective case-control study assessed human papillomavirus 16...
29th October, 2009
Applied Molecular Biology Research Group, Laboratory for Cell Biology and Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9. Epub 2009 Oct
DOI Direct Link
Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future.
For more than 20 years already, researchers from all over the world have...
23rd October, 2009
Applied Molecular Genomics Group, Vlaams Instituut voor Biotechnologie Hum Mutat. 2009 Aug;30(8):1139-52.
DOI Direct Link
Dissection of sigma(E)-dependent cell lysis in Escherichia coli: roles of RpoE regulators RseA, RseB and periplasmic folding catalyst PpiD.
To understand the mechanism of sigma(E)-dependent cell lysis, we examined...
23rd October, 2009
Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi Genes Cells. 2009 Jul;14(7):885-99. Epub 2009 Jun 22.
DOI Direct Link

View more Applied Molecular research publications.

Press Releases on Applied Molecular:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
MorphoSys Reports third quarter 2004 results. Company expects to obtain 1st September, 2004 Morphosys
MorphoSys Reports third quarter 2004 results. Company expects to obtain profitablity by 2005 Martinsried/Munich, October 28, 2004 MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime

BioNews Results for Applied Molecular:

BioTrove poised for acquisition, new spin-out
Mass High Tech:  Nov 11 2009 2:35PM Matching: applied molecular
IDBS Expands in Asia Pacific
Business Computing World:  Nov 10 2009 9:48PM Matching: applied molecular
Eli Lilly Units Pumping Up Drug Pipeline
San Diego Business Journal:  Nov 9 2009 5:50PM Matching: applied molecular
Biotech Blooms at Eli Lilly
Cafepharma:  Nov 9 2009 4:56PM Matching: applied molecular
Biotech Blooms at Eli Lilly
Seeking Alpha:  Nov 8 2009 4:44PM Matching: applied molecular
Promote your company here: BioNewsCast - Press Release Distribution

View more Applied Molecular news.

Applied Molecular Clinical Trials:

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma

Applied Molecular Patents:

US Patent No.Title
7575747 A.beta. binding molecules
6787638 Tumor specific human monoclonal antibodies and methods of use
6893845 Surface expression libraries of heteromeric receptors
7049121 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
7070973 Butyrylcholinesterase variants and methods of use

View more Applied Molecular patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 12 individuals from Applied Molecular using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 531 times since April 2007, the link to the organisation's website has been followed 90 times

Search for more companies in San Diego

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Applied Molecular

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.